{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:04:37Z","timestamp":1794852277152,"version":"4.9.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:00:00Z","timestamp":1692748800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["17im0210105h0202"],"award-info":[{"award-number":["17im0210105h0202"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["18pc0101024h0001"],"award-info":[{"award-number":["18pc0101024h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["19lm0203057h0402"],"award-info":[{"award-number":["19lm0203057h0402"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019702","name":"Tokyo Metropolitan Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019702","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["17K15584"],"award-info":[{"award-number":["17K15584"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["19K07115"],"award-info":[{"award-number":["19K07115"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["21K06981"],"award-info":[{"award-number":["21K06981"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.biopha.2023.115379","type":"journal-article","created":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T13:03:37Z","timestamp":1693227817000},"page":"115379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Molecular insights of a CBP\/\u03b2-catenin-signaling inhibitor on nonalcoholic steatohepatitis-induced liver fibrosis and disorder"],"prefix":"10.1016","volume":"166","author":[{"given":"Kenzaburo","family":"Yamaji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadahiro","family":"Iwabuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Tokunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Yamane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakiko","family":"Toyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa","family":"Kono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bouchra","family":"Kitab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Tsukiyama-Kohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Osawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsunekazu","family":"Hishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chise","family":"Tateno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9352-4721","authenticated-orcid":false,"given":"Kiminori","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Okanoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2130-5837","authenticated-orcid":false,"given":"Michinori","family":"Kohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2023.115379_bib1","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/hep4.1599","article-title":"The growing burden of disability related to nonalcoholic fatty liver disease: data from the global burden of disease 2007-2017","volume":"4","author":"Paik","year":"2020","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.biopha.2023.115379_bib2","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2023.115379_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2023.115379_bib4","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2023.115379_bib5","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2023.115379_bib6","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92264","article-title":"Interspecies NASH disease activity whole-genome profiling identifies a fibrogenic role of PPARalpha-regulated dermatopontin","volume":"2","author":"Lefebvre","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.biopha.2023.115379_bib7","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2023.115379_bib8","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2023.115379_bib9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2023.115379_bib10","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jhep.2017.07.027","article-title":"Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD","volume":"67","author":"Hagstrom","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2023.115379_bib11","doi-asserted-by":"crossref","first-page":"42762","DOI":"10.18632\/oncotarget.8641","article-title":"Utilization of animal models to investigate nonalcoholic steatohepatitis-associated hepatocellular carcinoma","volume":"7","author":"Wu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2023.115379_bib12","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41467-022-28138-6","article-title":"Formyl peptide receptor 2 determines sex-specific differences in the progression of nonalcoholic fatty liver disease and steatohepatitis","volume":"13","author":"Lee","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2023.115379_bib13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/iep.12008","article-title":"An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis","volume":"94","author":"Matsumoto","year":"2013","journal-title":"Int J. Exp. Pathol."},{"key":"10.1016\/j.biopha.2023.115379_bib14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/iep.12240","article-title":"Hepatocellular carcinoma in a mouse model fed a choline-deficient, L-amino acid-defined, high-fat diet","volume":"98","author":"Ikawa-Yoshida","year":"2017","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.biopha.2023.115379_bib15","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1681\/ASN.2010101079","article-title":"Targeted inhibition of beta-catenin\/CBP signaling ameliorates renal interstitial fibrosis","volume":"22","author":"Hao","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2023.115379_bib16","doi-asserted-by":"crossref","first-page":"14309","DOI":"10.1073\/pnas.1001520107","article-title":"Inhibition of Wnt\/beta-catenin\/CREB binding protein (CBP) signaling reverses pulmonary fibrosis","volume":"107","author":"Henderson","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2023.115379_bib17","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.ebiom.2015.10.010","article-title":"Inhibition of cyclic adenosine monophosphate (cAMP)-response element-binding protein (CREB)-binding protein (CBP)\/beta-catenin reduces liver fibrosis in mice","volume":"2","author":"Osawa","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.biopha.2023.115379_bib18","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/s41598-017-00282-w","article-title":"Selective inhibitor of Wnt\/beta-catenin\/CBP signaling ameliorates hepatitis C virus-induced liver fibrosis in mouse model","volume":"7","author":"Tokunaga","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2023.115379_bib19","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.21873\/anticanres.14524","article-title":"Anti-tumor activity of the small molecule inhibitor PRI-724 against beta-catenin-activated hepatocellular carcinoma","volume":"40","author":"Gabata","year":"2020","journal-title":"Anticancer Res."},{"key":"10.1016\/j.biopha.2023.115379_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104069","article-title":"Safety, tolerability, and anti-fibrotic efficacy of the CBP\/beta-catenin inhibitor PRI-724 in patients with hepatitis C and B virus-induced liver cirrhosis: an investigator-initiated, open-label, non-randomised, multicentre, phase 1\/2a study","volume":"80","author":"Kimura","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.biopha.2023.115379_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2022-001001","article-title":"Feasibility, safety and tolerability of the CREB-binding protein\/beta-catenin inhibitor OP-724 in patients with advanced primary biliary cholangitis: an investigator-initiated, open-label, non-randomised, two-centre, phase 1 study","volume":"9","author":"Kimura","year":"2022","journal-title":"BMJ Open Gastroenterol."},{"key":"10.1016\/j.biopha.2023.115379_bib22","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1053\/j.gastro.2009.03.061","article-title":"Hepatitis C virus and disrupted interferon signaling promote lymphoproliferation via type II CD95 and interleukins","volume":"137","author":"Machida","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2023.115379_bib23","doi-asserted-by":"crossref","first-page":"14225","DOI":"10.1038\/s41598-017-14676-3","article-title":"Comprehensive single-cell transcriptome analysis reveals heterogeneity in endometrioid adenocarcinoma tissues","volume":"7","author":"Hashimoto","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2023.115379_bib24","doi-asserted-by":"crossref","first-page":"8961","DOI":"10.1093\/nar\/gkz706","article-title":"Reconstructing complex lineage trees from scRNA-seq data using MERLoT","volume":"47","author":"Parra","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2023.115379_bib25","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","article-title":"Fast and accurate long-read alignment with Burrows-Wheeler transform","volume":"26","author":"Li","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.biopha.2023.115379_bib26","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nbt.4096","article-title":"Integrating single-cell transcriptomic data across different conditions, technologies, and species","volume":"36","author":"Butler","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biopha.2023.115379_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13073-020-00756-z","article-title":"Discovery of CD80 and CD86 as recent activation markers on regulatory T cells by protein-RNA single-cell analysis","volume":"12","author":"Trzupek","year":"2020","journal-title":"Genome Med"},{"key":"10.1016\/j.biopha.2023.115379_bib28","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/hepr.12819","article-title":"Establishment of mouse Mac-2 binding protein enzyme-linked immunosorbent assay and its application for mouse chronic liver disease models","volume":"47","author":"Iwata","year":"2017","journal-title":"Hepatol. Res"},{"key":"10.1016\/j.biopha.2023.115379_bib29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-981-13-6037-4_4","article-title":"Nx1-seq (well based single-cell analysis system)","volume":"1129","author":"Hashimoto","year":"2019","journal-title":"Adv. Exp. Med Biol."},{"key":"10.1016\/j.biopha.2023.115379_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108626","article-title":"Dynamic shifts in the composition of resident and recruited macrophages influence tissue remodeling in NASH","volume":"34","author":"Daemen","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2023.115379_bib31","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","article-title":"Resolving the fibrotic niche of human liver cirrhosis at single-cell level","volume":"575","author":"Ramachandran","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2023.115379_bib32","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jhep.2016.05.037","article-title":"Bone marrow-derived and resident liver macrophages display unique transcriptomic signatures but similar biological functions","volume":"65","author":"Beattie","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2023.115379_bib33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2036.2007.03369.x","article-title":"Review article: the prothrombin time test as a measure of bleeding risk and prognosis in liver disease","volume":"26","author":"Tripodi","year":"2007","journal-title":"Aliment Pharm. Ther."},{"key":"10.1016\/j.biopha.2023.115379_bib34","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/hep.510240613","article-title":"Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio?","volume":"24","author":"Robert","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2023.115379_bib35","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/s41591-021-01344-3","article-title":"XCR1(+) type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis","volume":"27","author":"Deczkowska","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2023.115379_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243846","article-title":"The antihypertensive agent hydralazine reduced extracellular matrix synthesis and liver fibrosis in nonalcoholic steatohepatitis exacerbated by hypertension","volume":"15","author":"Yuan","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2023.115379_bib37","first-page":"507","article-title":"SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease","volume":"21","author":"Kohjima","year":"2008","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.biopha.2023.115379_bib38","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12920-018-0438-7","article-title":"Genomics of lipid-laden human hepatocyte cultures enables drug target screening for the treatment of non-alcoholic fatty liver disease","volume":"11","author":"Breher-Esch","year":"2018","journal-title":"BMC Med. Genom."},{"key":"10.1016\/j.biopha.2023.115379_bib39","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.bbrc.2017.11.054","article-title":"Pyruvate dehydrogenase kinase 4 mediates lipogenesis and contributes to the pathogenesis of nonalcoholic steatohepatitis","volume":"495","author":"Zhang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2023.115379_bib40","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jmb.2007.06.091","article-title":"Three members of the human pyruvate dehydrogenase kinase gene family are direct targets of the peroxisome proliferator-activated receptor beta\/delta","volume":"372","author":"Degenhardt","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.biopha.2023.115379_bib41","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1080\/01902148.2019.1638466","article-title":"The novel inhibitor PRI-724 for Wnt\/beta-catenin\/CBP signaling ameliorates bleomycin-induced pulmonary fibrosis in mice","volume":"45","author":"Okazaki","year":"2019","journal-title":"Exp. Lung Res."},{"key":"10.1016\/j.biopha.2023.115379_bib42","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf7533","article-title":"Loss of HDAC3 results in nonreceptive endometrium and female infertility","volume":"11","author":"Kim","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biopha.2023.115379_bib43","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1136\/gutjnl-2019-318382","article-title":"Myeloid cells in liver and bone marrow acquire a functionally distinct inflammatory phenotype during obesity-related steatohepatitis","volume":"69","author":"Krenkel","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2023.115379_bib44","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1038\/s41467-018-06318-7","article-title":"Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations","volume":"9","author":"MacParland","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2023.115379_bib45","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1158\/1535-7163.MCT-11-0182","article-title":"Inhibition of the acetyltransferases p300 and CBP reveals a targetable function for p300 in the survival and invasion pathways of prostate cancer cell lines","volume":"10","author":"Santer","year":"2011","journal-title":"Mol. Cancer Ther."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223011769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223011769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T06:56:56Z","timestamp":1782370616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223011769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":45,"alternative-id":["S0753332223011769"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115379","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular insights of a CBP\/\u03b2-catenin-signaling inhibitor on nonalcoholic steatohepatitis-induced liver fibrosis and disorder","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115379","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115379"}}